Recent studies on a few individuals at high risk of T2D with repeated multi-omics measures [77••, 78] provide proof of principle of the utility of multi-omics to improve predictive modelling for insulin resistance and to identify individual disease trajectories that integrate molecular events across these layers of information. This evidence concerns the gene INS and type 2 diabetes mellitus.